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Highlights 
• Orexins are involved in the regulation of stress response 
• The HCRTR1 rs2271933 G>A genotype was associated with aggressiveness  
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• The genotype effect is sensitive to stressful life events   
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Abstract  
Orexins, alternatively called hypocretins, are neuropeptides with crucial role in maintaining 
wakefulness. The orexin system is thought to mediate a coordinated defense response but 
thus far investigated from the flight, but never fight, response perspective. An HCRTR1 gene 
variant (rs2271933 G > A) leading to amino acid substitution (Ile408Val) has been associated 
with migraine and mood disorders. We genotyped, and assessed aggressive behaviour in both 
birth cohorts (n=655 and 583) of the Estonian Children Personality Behaviour and Health 
Study (ECPBHS). Measures of aggressiveness were collected at age 25 or 33 and data on 
stressful life events (SLE-s) at age 15. Violations of traffic law were monitored in the 
samples of the Estonian Psychobiological Study of Traffic Behaviour. In both birth cohorts of 
the ECPBHS, the HCRTR1 the A/A homozygotes reported higher aggression in both Buss-
Perry Aggression Questionnaire and the Life History of Aggression Interview. With either 
measure of aggressiveness, the HCRTR1 genotype effect was dependent on experience of 
SLE, the highest level of aggressiveness increase by environment being found in female A/A 
homozygotes. The HCRTR1 A/A homozygotes scored higher in the ANGER facet of the 
Affective Neuroscience Personality Scale, while such an effect on FEAR was found only in 
females. Male HCRTR1 A/A homozygotes were more likely to relapse into drunk driving of a 
passenger car, and in two independent samples the A-allele carriers were causing traffic 
accidents more often. Conclusively, self-report, interview, and traffic record data converge 
indicating that the HCRTR1 Ile408Val genotype is associated with aggressiveness and breach 
of law. 
This article is part of the Special Issue entitled “Current status of the neurobiology of 
aggression and impulsivity”. 
1. Introduction 
Orexins or hypocretins are hypothalamic neuropeptides derived from prepro-orexin (Sakurai 
et al., 1998; de Lecea et al., 1998) that have been implicated in a large variety of 
physiological functions, most clearly in sleep/wake regulation (Sutcliffe and de Lecea, 2000; 
Schwartz and Kilduff, 2015) and food intake (Sutcliffe and de Lecea, 2000; Broberger and 
Hökfelt, 2001; Ferrario et al., 2016). Orexin neurons are located in the dorsomedial and 
lateral hypothalamus, in particular in perifornical and magnocellular lateral hypothalamic 
nucleus (Broberger et al., 1998). More recently, orexins have been proposed to be involved in 
a coordinated adaptive defence response, in particular its anxiety, cardiorespiratory and 
endocrine aspects (Johnson et al., 2012). Orexins modulate neural circuits implicated in the 
expression and extinction of fear memories (Flores et al., 2015). The orexin system is 
activated during the acute stress response, but the effects of chronic stress on the orexin 
system are thought to be highly variable (Sargin, 2018). As orexin neurons are activated by a 
large variety of stressors, a hypothesis has been put forward that orexin neurotransmission is 
particularly important in behavioural regulation during aversive conditions involving high 
arousal (Berridge et al., 2010). Suicide attempters with major depression were found to have 
lower CSF levels of orexin as compared to other patient groups (Brundin et al., 2007), 
indirectly suggesting that orexin is important in maintaining adaptive strategies that are 
sensitive to mood regulation.  
If the orexin peptides are crucial mediators of coordinated stress response, then the other side 
of the fight-flight response, the possible choice of fight and preference of confrontational and 
aggressive response over escape should also be examined (Dhabhar, 2018). In a unique study 
on epileptic patients the release of orexin A was monitored in amygdala and found to be 
increased while subjects reported higher levels of anger (Blouin et al., 2013). Otherwise little 
evidence appears to exist on the role of orexins in any aspects of aggressive behaviour. 
Aggressiveness is however an important component of coordinated adaptive response to 
challenges presented by the environment (Van Kampen, 2015) and different nuclei of the 
hypothalamus play a critical role in this response (Kruk, 2014). Administration of orexin A 
has been reported to elicit dose-dependent complex changes in mouse maternal behaviour, 
including, at high doses, reduction of maternal behaviour and aggression (D'Anna and 
Gammie, 2006). Otherwise, no evidence for a role of orexins in aggressive behaviour has 
previously been made available. Nevertheless, orexin neurons project to such brain regions as 
septum and locus coeruleus that have a wellknown role in aggressiveness, and into emotion 
intergrative areas such as amygdala and the bed nucleus of stria terminalis. These brain 
regions also express type 1 orexin receptors (Flores et al., 2015). 
Polymorphism of the orexin prepropeptide gene seems rather limited in humans, but several 
polymorphisms have been identified in the HCRTR1 and HCRTR2 genes encoding their 
receptors (Thompson et al., 2014). One HCRTR1 gene variant (rs2271933, G1222A) in exon 
7 leads to amino acid substitution (Ile408Val) (Meerabux et al., 2005). This variant has been 
associated with migraine (Rainero et al., 2011b) and mood disorders (Rainero et al., 2011b). 
In migraine patients, aggressive behaviour is commonly observed, and their aggressiveness 
strongly correlates with symptoms of depression (Robbins, 2013; Park and Seo, 2018). Hence 
we sought to determine, by use of this marker, whether variation in the HCRTR1 gene can be 
associated with aggressiveness in two independent samples. Furthermore, taking advantage of 
a unique database of traffic behaviour, a common behaviour that may include breach of law 
that is objectively recorded, we studied the association of the HCRTR1 genotype with drunk 
driving and involvement in accidents in two samples. 
2. Material and methods 
2.1. Subjects 
2.1.1. The longitudinal Estonian Children Personality Behaviour and Health Study 
Assessment of aggressiveness in this investigation has been carried out on two independent 
samples included in the Estonian Children Personality Behaviour and Health Study 
(ECPBHS). We used its original EYHS subsample that comprises two birth cohorts. At 
recruitment the children were at either third (younger cohort, average age 9.6 years, 52.3% 
female) or ninth (older cohort, average age 15.6 years, 56.2% female) grade; the participation 
rate was 79.1%. The rationale of sample selection and procedure has been described 
previously (Harro et al., 2001), and the recent data collection waves up to age 25 have been 
described in more detail elsewhere (e.g., Kiive et al., 2017; Laas et al., 2017). Data on 
aggressiveness and affective aspects of personality were collected in the most recent data 
collection waves, i.e., at age 25 for the younger cohort and age 33 for the older cohort. The 
number of participants was 441 and 504, respectively. All participants signed an informed 
consent form. The ECPBHS has been approved by the Tartu University Ethics Review 
Committee on Human Research. 
2.1.2. Samples of the traffic studies 
We also genotyped the subjects of two longitudinally observed samples from the Estonian 
Psychobiological Study on Traffic Behaviour (EPSTB) in order to examine the association of 
the HCRTR1 genotype with objectively recorded antisocial behaviour. The EPSTB Sample 1 
comprised subjects recruited in studies of drunk drivers and speed limit exceeders (see 
Eensoo et al., 2005 and Paaver et al., 2006 for detailed description). This group of drivers 
included male subjects who were identified by the police driving drunk at least once during 
the previous year (n=203; mean age ± SD, 33 ± 11 years) or exceeding speed limits (n=292; 
mean age 36 ± 11 years). The control group was formed by computerised random choice of 
the male subjects in the driving licence database of the Estonian Motor Vehicle Registration 
Centre; it consisted of 509 individuals, with a mean age of 37 ± 12 years. Subjects were 
contacted by telephone, the description and aims of the study were provided, and they filled 
in self-reported questionnaires during a visit to laboratory where they donated venous blood 
samples. The EPSTB Sample 2 was formed during an impulsivity-focused intervention study 
at traffic schools (Paaver et al., 2013; Eensoo et al., 2018). Of the 1886 participants (mean 
age 23.0 ± 7.2 years) of the intervention study, altogether 767 subjects (41% male) had 
agreed to donate a blood sample. All participants signed an informed consent form. This 
study was approved by the Tartu University Ethics Review Committee on Human Research. 
2.2. Genotyping HCRTR1 rs2271933 
Genomic DNA was extracted from venous blood samples using Qiagen QIAamp® DNA 
Blood Midi Kit. The real-time polymerase chain reaction (RT-PCR) for genotyping the 
HCRTR1 rs2271933 polymorphism was performed using a TaqMan Pre-Designed SNP 
Genotyping Assay (Applied Biosystems; Foster City, CA, USA) C__15961465_10 
containing primers and fluorescent probes. Genotyping reactions were performed in a total 
volume of 10 μl with ∼25 ng of template DNA. RT-PCR reaction components and final 
concentrations were as follows: 1:5 5 x HOT FIREPol® Probe qPCR Mix Plus (ROX) (Solis 
BioDyne) and 1:20 80 x TaqMan Primers Probe. Context sequence [VIC/FAM] was as 
follows: 
CTTGTCCTTGCAGAGCCGATGCTCC[A/G]TCTCCAAAATCTCTGAGCATGTGGT. 
Reactions were performed on the Applied Biosystems ViiA™ 7 Real-Time PCR System. The 
amplification procedure consisted of an initial denaturation step at 95 °C for 12 min and 40 
cycles of 95 °C for 15 s and 60 °C for 1 min. Positive and negative controls were added to 
each reaction plate. No inconsistencies occurred. Genotyping was performed blind to all 
phenotypic data. Allele frequencies agreed with National Centre for Biotechnology 
Information database (minor allele frequency around 
0.4; https://www.ncbi.nlm.nih.gov/snp/rs2271933#frequency_tab) and published reports. All 
the subjects were of European origin, and genotype frequencies of all samples were in Hardy-
Weinberg equilibrium (Table 1). 
Table 1. HCRTR1 rs2271933 genotype frequencies in samples included in this investigation. 
 A/A A/G G/G Total 
ECPBHS total 185 (15%) 610 (50%) 439 (35%) 1234 (100%) 
ECPBHS younger 
cohort 
75 (13%) 309 (53%) 196 (34%) 580 (100%) 
ECPBHS older 
cohort 
110 (17%)  301 (46%) 243 (37%)  654 (100%) 
EPSTB Sample 1 160 (16%) 467 (48%) 357 (36%) 984 (100%) 
EPSTB Sample 2 132 (17%) 371 (48%) 273 (35%) 776 (100%) 
Minor allele frequency 0.40. For comparison, around 0.40 in European samples in the NCBI database; 0.367 in 
the 1000G CEU population (https://www.ncbi.nlm.nih.gov/snp/rs2271933#frequency_tab). 
 
2.3. Measures of aggressiveness 
2.3.1. Self-report questionnaire 
The 29-item Buss-Perry Aggression Questionnaire (BPAQ; Buss and Perry, 1992) assesses 
four aspects of aggressive behaviour: Physical aggression, Verbal aggression, Anger, and 
Hostility. Participants rated each statement on a 5-point Likert Scale (uncharacteristic = 1, 
characteristic = 5). Data of Buss-Perry Aggression Questionnaire were available for 427 
subjects in the younger ECPBHS cohort and for 499 subjects in the older cohort. 
2.3.2. Aggressiveness interview 
The Life History of Aggression interview (LHA; Coccaro et al., 1997) was carried out by an 
experienced clinical psychologist. Items were scored only for the history of actual behaviour. 
LHA has three subscales: Aggression (temper tantrums, verbal aggression, indirect 
aggression, non-specific fighting, and physical assault against people); 
Consequences/Antisocial Behaviour (school disciplinary problems, problems with 
supervisors, antisocial behaviour not resulting in police involvement, and antisocial 
behaviour involving the police); and Self-Directed Aggression (self-injurious behaviour, and 
suicide attempts). Each item was rated on a 5-point scale, ranging from 0 = No events to 5 = 
More events than can be counted. Data of LHA were available for 427 subjects in the 
ECPBHS younger cohort and 495 subjects in the older cohort. Overall, Aggression assessed 
by interview was moderately correlated to measures of BPAQ self-reported aggressiveness in 
both sexes while Antisocial Behaviour was associated to self-reports moderately in males and 
weakly in females (Supplementary Table 1). Correlation of Self-directed Aggression with 
other measures was weak. 
2.4. Affective Neuroscience Personality Scale 
We used the adaptation of the short version of the ANPS (Davis et al., 2003) that is a self-
report instrument constructed bottom-up to correspond to the activity in neural circuits 
underlying basic emotive systems as defined in animal research (Panksepp, 1998; Davis and 
Panksepp, 2011). It comprises scales termed ANGER, FEAR, SADNESS, SEEKING, CARE 
and PLAY, each measured with six items, each on a 5-point scale. Data on ANPS were 
available for 423 subjects in the ECPBHS younger cohort and 502 subjects in the older 
cohort. 
2.5. Stressful life events 
Stress experienced in childhood was measured at age 15 with a list of 21 adverse life 
experiences reported by participants or their parents, which included questions about parental 
death and divorce/separation, absence of both parents, unemployment in the family, financial 
problems and poverty in the household, poor living conditions, poor health and chronic 
diseases, serious illness of a family member, death of a close relative, trauma, fear of school, 
bullying at school and humiliation at home (Laas et al., 2014). The events were recorded as 
dichotomous variables (present or not present) and were then counted to form the number of 
experienced stressful life events (SLE15). The SLE distribution did not differ between males 
and females. Data were available for 478 subjects in the ECPBHS younger cohort and for 591 
subjects in the older cohort. 
2.6. Database search 
Data on violations of traffic law and traffic accidents were obtained from databases 
maintained by the traffic police and the traffic insurance fund for the period of January 1, 
2002 to December 31, 2011 for the EPSTB Sample 1 and for the period of January 1, 2007 to 
December 31, 2011 for the EPSTB Sample 2 (Eensoo et al., 2018). We focused on driving 
while impaired by alcohol (DWI; penalties for drunk driving with an estimated blood alcohol 
level of 0.2‰ or more) and traffic accidents. The accidents where the subject was at fault 
were classified as active accidents, and other accidents as passive. 
2.7. Statistical analysis 
Data were analysed using IBM SPSS (version 22.0, Chicago, IL) and SAS (version 9.4 SAS 
Inc., Cary, NC) software. One- and two-way analyses of variance were performed to reveal 
differences between HCRTR1 genotypes with and without consideration of stressful life 
events (dichotomized by median split). When appropriate Tukey post-hoc tests were applied. 
We also used a series of multiple linear regressions for predicting the aggressiveness-related 
scores where we added all the simple terms and interaction terms to the models 
simultaneously. To increase interpretability and minimize collinearity in the models, 
predictors were centered according to Kraemer and Blasey (2004), and interaction terms were 
residuals-centered according to Little et al. (2006). Number of stressful life events were 
treated as quantitative variable for regression analysis. Models were evaluated by goodness of 
fit statistics and analyses of residuals. Chi-square tests were conducted to assess distribution 
of presence of traffic violations and accidents by genotype. The conventional 5% level was 
applied, given that this is the first exploratory study on the association of the orexin receptor 
genotype and aggressiveness measures, and that the latter are significantly inter-correlated. 
Retrospective power calculations indicated that if the effects were small the power was low, 
too, starting from 0.584 in case of p-value 0.050. However, in all analyses where the p-value 
was ≤0.008, the power was adequate (≥0.8). 
3. Results 
3.1. HCRTR1 genotype and aggressiveness in the two population-representative birth 
cohorts 
In the ECPBHS younger cohort aggressiveness was assessed at age 25. The HCRTR1 
Ile408Val (G/A) genotype was significantly associated with total score of the Buss-Perry 
Aggression Questionnaire [F (2,424) = 4.36; p = 0.013; η2 = 0.020], the A/A homozygotes 
reporting higher hostility, anger and physical aggression (Fig. 1A and Supplementary Table 
2). Similarly, the genotype was associated with the total score of the Lifetime History of 
Aggression interview [F (2,424) = 6.98; p = 0.001; η2 = 0.032] and its major subscale 
Aggression (Fig. 1B and Supplementary Table 2), the A/A homozygotes reporting higher 
level of aggressiveness. 
Thereafter the ECPBHS older cohort was independently examined for aggressiveness at age 
33. The findings were essentially similar: The total score of the BPAQ was significantly 
higher in the A/A homozygotes [F (2496] = 3.43; p = 0.033; η2 = 0.014], with significant 
differences in anger and physical aggression (Fig. 2A and Supplementary Table 2). The 
HCRTR1 genotype was also significantly associated with the LHA Aggression subscale (Fig. 
2B and Supplementary Table 2) as well as with self-directed aggression, while regarding total 
score the conventional level of statistical significance was missed (p=0.06). Given the 
similarity of the genotype effect on these primary outcome measures in both cohorts, further 
stratified analyses used the data of the birth cohorts combined.  
 
 
Fig. 1. HCRTR1 genotype and aggressiveness in the younger ECPBHS birth cohort at age 25. A - 
Buss-Perry Aggression Questionnaire (BPAQ) total score; number of subjects A/A = 53, A/G = 230, G/G = 144; 
B - Life History of Aggression (LHA) interview Aggression subscale; number of subjects A/A = 53, A/G = 230, 
G/G = 144. * - p < 0.05, ** - p < 0.01, *** - p < 0.001 difference between genotypes. Whiskers indicate 95% 
confidence intervals. 
 
 
Fig. 2. HCRTR1 genotype and aggressiveness in the older ECPBHS birth cohort at age 33. A - Buss-
Perry Aggression Questionnaire (BPAQ) total score; number of subjects A/A = 84, A/G = 232, G/G = 183; B - 
Life History of Aggression (LHA) interview Aggression subscale; number of subjects A/A = 83, A/G = 230, 
G/G = 182. * - p < 0.05 difference between genotypes. 
Analysis of both cohorts together revealed highly significant genotype effects on the BPAQ 
and LHA total scores and most aspects of aggressive behaviour (Supplementary Table 2). No 
genotype by sex interaction was statistically significant (data not shown). 
3.2. HCRTR1 genotype and the Affective Neuroscience Personality Scale 
Based on the findings above we developed an a priori hypothesis that the HCRTR1 genotype 
should be associated with scores of the ANGER scale, and given the literature on stress 
reactivity and orexin, possibly with the FEAR scale, as a large share of overall aggressiveness 
is of defensive type. Indeed we found that ANGER was significantly higher in the A/A 
homozygotes [F (2, 927) = 6.39; p = 0.002; η2 = 0.014]; this was the case in both males and 
females (Table 2). As to FEAR, the genotype main effect missed the conventional level of 
significance [F (2, 927) = 2.44; p = 0.088; η2 = 0.005] and no statistically significant 
genotype × sex interaction emerged [F (2,924)=2.36; p=0.095; η2=0.005], but the scores 
were much higher in females, so we analysed the sexes separately. While in males the 
genotypes were identical [F (2, 396) < 0.01; p = 0.997; η2 < 0.001], a variation appeared 
among females [F (2, 396) = 5.09; p = 0.006; η2 = 0.019]. The female A/A homozygotes had 
the highest levels of FEAR scores. Exploratory analysis of other affect domains (Table 2)  
Table 2. HCRTR1 genotype and the Affective Neuroscience Personality Scale scores in both 
ECPBHS birth cohorts combined, by sex.  
 Males  Females 
 AA AG GG  AA AG GG 
ANGER 17.5±4.4 15.9±4.4* 16.0±4.5*  18.2±4.5 16.6±4.4* 17.1±5.0 
FEAR 15.7±3.3 15.7±3.1 15.8±3.0  18.2±3.5 16.8±3.3** 17.4±3.3 
SADNESS 13.5±4.0 13.1±4.1 13.0±4.2  16.2±4.8 15.0±4.7 15.6±5.0 
SEEKING 23.5±2.9 23.0±3.7 22.7±3.6  22.2±3.4# 23.2±3.5 23.2±3.6 
CARE 20.6±4.2 20.0±3.9 20.5±3.8  23.1±3.0 22.7±3.6 23.2±3.5 
PLAY 22.5±4.6 22.1±3.9 22.1±3.9  21.9±4.0 22.7±3.8 22.6±4.5 
Mean ± S.D. * - p < 0.05, ** - p < 0.01, difference from A/A genotype in the same sex. # - p < 0.05, difference 
from the A/A male genotype. Genotype frequencies: Males, A/A = 61, A/G = 193, G/G = 145; Females, A/A = 
74, A/G = 273, G/G = 184. 
 
revealed no main effect of genotype, but a genotype × sex interaction was revealed for 
SEEKING [F (2, 924) = 3.25; p = 0.040; η2 = 0.016]. This was owing to the relatively higher 
SEEKING score of the A/A males contrasted to the relatively low SEEKING in A/A females 
(Table 2). 
3.3. HCRTR1 genotype and stressful life events (SLE): interaction effect on 
aggressiveness 
Three-way ANOVA-s as well as multidimensional linear regression analysis suggested the 
presence of HCRTR1 genotype × SLE × sex interactions for the BPAQ and LHA measures 
(Supplementary Tables 3 and 4). Higher level of experience of stressful life events by age 15 
had a general tendency, in some genotype-wise comparisons statistically significant, to 
increase aggressiveness, except in the group with highest aggressiveness, the male A/A 
homozygotes (Fig. 3). In females, higher exposure to SLE-s was in A/A homozygotes 
associated with a dramatic increase. This was the case for both questionnaire (BPAQ) and 
interview (LHA) measures. 
 
Fig. 3. Aggressiveness by HCRTR1 genotype, level of exposure to stressful life events and sex. Panel 
A: Buss-Perry Aggression Questionnaire. Number of males: Low SLE, A/A= 27, A/G = 107, G/G =79; High 
SLE, A/A= 24, A/G = 60, G/G =49. Number of females: Low SLE, A/A= 40, A/G = 157, G/G =106; High SLE, 
A/A=26, A/G=92, G/G=59. Panel B: Lifetime History of Aggression. Number of males: Low SLE, A/A=28, 
A/G=108, G/G=80; High SLE, AA=24, AG=59, GG =50. Number of females: Low SLE, A/A=38, A/G=154, 
G/G=103; High SLE, A/A=26, A/G=93, G/G=59. * - p<0.05, ** - p <0.01, *** - p<0.001 difference between 
genotypes. Whiskers indicate 95% confidence intervals. 
 
 
 
3.4. HCRTR1 genotype and re-occurrence of driving while impaired 
Fig. 4 presents the occurrence of drunk driving during the observation period by year. While 
some cases of DWI appeared over the years in the random control group and among the 
speed limit exceeders, the subjects recruited owing to a recorded episode of drunk driving 
had the levels of relapse that far exceeded the prevalence of DWI in other groups. This re-
occurrence of DWI was however related to the HCRTR1 genotype (Supplementary Table 5). 
Higher re-occurrence of DWI in the HCRTR1 A/A homozygotes appeared soon after initial 
recruitment, became statistically significant at the sixth year of follow-up (DF = 2, χ2 = 7.4, 
p= 0.025) and remained so until the last year of follow-up (DF = 2, χ2 = 7.7, p=0.022). At the 
recruitment, the drunk drivers, speed limit exceeders and controls were not different in terms 
of genotype distribution (data not shown). 
3.5. HCRTR1 genotype and involvement in traffic accidents  
We examined in this sample whether or not the HCRTR1 genotype could be related to 
involvement of the participants in traffic accidents. It was revealed that the accumulation of 
active traffic accidents in the DWI group was higher in the A-allele carriers (Fig. 5 and 
Supplementary Table 5). A tendency for this was present early in the observation period but 
as the cases accumulated this trend became statistically significant by the seventh year of 
observation (χ2 = 4.2, p = 0.041) and remained so until the last year examined (χ2 = 5.0, 
p=0.025). Similar findings were present in an independent sample of passenger car drivers 
observed since they entered the study (Fig. 6 and Supplementary Table 5). In this sample the 
number of the HCRTR1 A-alleles seemed associated with the involvement of traffic 
accidents, and in particular with active accidents, but statistical significance was found in 
comparison of either A/A homozygotes or A-allele carriers with G/G homozygotes. 
 
 
Fig. 4. Cumulative occurrence of driving while 
impaired in 2002–2011 by year in subjects 
recruited in 2001–2003, by the HCRTR1 
genotype. The Y-axis represents the proportion of 
subjects with the given genotype who had by that 
year driven vehicle while intoxicated. For the drunk 
drivers group this refers to re-occurrence. * - p < 
0.05, difference from the A/A genotype. Genotype 
frequency: Controls, A/A = 80, A/G = 190, G/G = 
160; Speed limit exceeders, A/A = 34, A/G = 121, 
G/G = 78; Drunk drivers A/A = 29, A/G = 91, G/G 
= 71. 
 
 
 
Fig. 5. Cumulative occurrence of active traffic 
accidents in 2002–2011 by year in subjects 
recruited in 2001–2003, by the HCRTR1 
genotype. The Y-axis represents the proportion of 
subjects with the given genotype who had by that 
year caused a traffic accident. * - p<0.05, 
difference from the A-allele carriers. Genotype 
frequency: Controls, A-allele carriers = 270, G/G = 
160; Speed limit exceeders, A-allele carriers = 151, 
G/G = 78; Drunk drivers, A-allele carriers = 120 
G/G = 71. 
 
 
 
 
 
 
  
 Fig. 6. Cumulative occurrence of total number (A and B) and active (C and D) traffic accidents in 
2007–2011 by year in subjects recruited in 2007 at traffic schools, by the HCRTR1 genotype. The Y-
axis represents the proportion of subjects with the given genotype who had by that year been involved in a 
traffic accident. * - p < 0.05, difference from the A/A genotype; # - difference from the A-allele carriers. 
Genotype frequency: A/A=131, A/G=365, G/G=269. 
 
4. Discussion 
In this study we have demonstrated that the orexin system is associated with aggressiveness 
and accident-prone behaviour in humans. Specifically, homozygocity for the minor variant of 
the HCRTR1 gene (rs2271933, G1222A) that causes amino acid substitution (Ile408Val) was 
associated with aggressiveness measured with either self-reports or clinical interviews. While 
the paper-and-pencil and interview measures of aggressiveness are in positive correlation 
(Kiive et al., 2017 and this study), these correlations in birth cohort representative samples 
are not particularly high. Nonetheless, the genotype effect was apparently very similar with 
both types of measurement, suggesting that the HCRTR1 genotype is related to aspects of 
aggressiveness that are represented equally in these two instruments. Importantly, the 
findings in the younger ECPBHS birth cohort, assessed for aggressiveness at age 25 in 
2014/2015 were replicated in the older ECPBHS birth cohort assessed at age 33 in 
2016/2017. It is of notice that genotype associations with behavioural measures in these two 
birth cohorts have not been similar in a variety of previous analyses. Indeed, for behaviours 
with strong secular changes such as age of alcohol use debut, striking genotype by birth 
cohort interactions have been revealed (Vaht et al., 2014, 2016). These may be related to 
changes in attitudes toward alcohol use in adolescents and alcohol availability during the 
societal changes that were very rapid in some of the countries of Central and Eastern Europe 
during the period when the two birth cohorts were in critical age (Harro and Vaht, 2019). The 
high similarity of the association of the HCRTR1 genotype with two different measures of 
aggressive behaviour in these two cohorts not only provides a necessary replication of the 
original observation but also suggests that the HCRTR1 genotype has an effect on 
aggressiveness that transcends such gene-environment effects that stem from societal 
changes. 
Nevertheless, in females the HCRTR1 genotype effect was sensitive to stressful life events at 
the personal level. Again, the findings were similar with questionnaire and interview 
measures. Subjects with higher exposure to SLE in childhood had higher level of 
aggressiveness. This increase was small and not significant in female G/G homozygotes, and 
in the A/A males who had the highest levels of aggressiveness the stress exposure had not 
further effect, rather a nonsignificant trend towards reduction was observed. The interaction 
between genotype, SLE and sex was largely driven by the very large increase of 
aggressiveness in female A/A homozygotes with higher exposure to stress, while the female 
A/A homozygotes with low stress exposure did not differ from other genotypes. 
An initial attempt to understand the mediating mechanisms of the sex differences was made 
by examining the facets of the Affective Neuroscience Personality Scale in males and 
females. The ANPS (Davis and Panksepp, 2011) has been constructed bottom-up to measure 
the aspects of personality arising from persistent individual differences in the emotive 
phylogenetically old brain circuits and has been advocated for use in biologically oriented 
psychological studies (Montag and Reuter, 2014). Facets of the ANPS have been linked to 
characteristic patterns of resting state functional connectivity in the human brain (Deris et al., 
2017). We expected to observe higher ANGER in both male and female HCRTR1 A/A 
homozygotes, and this was found indeed. Scores of FEAR were higher in females than males, 
and in particular in female A/A homozygotes. Female A/A homozygotes also had the lowest 
scores of SEEKING of all sex by genotype groups, while the A/A males had the highest. 
Altogether these findings lead to speculation that in male A/A homozygotes the relatively 
high aggressiveness levels that are not dependent of the experience of life adversities 
originate from higher activities of neural systems for ANGER and SEEKING, the latter 
promoting resource orientated behaviour. In female A/A homozygotes the high sensitivity to 
stressful life events may emerge from higher FEAR and low SEEKING. However, as 
aggressiveness and the personality facets were assessed cross-sectionally in adulthood, this 
hypothesis requires examination in further longitudinal studies. 
It would be most important to know whether the higher aggressiveness in the HCRTR1 A/A 
homozygotes can lead to consequences in terms of real life behaviour. For this reason we 
genotyped the participants of a longitudinal study of traffic behaviour. Risky driving and 
traffic accidents are in strong relationship with aggressive and anxious states while driving, 
and share such affective and cognitive characteristics as emotional reactivity and threat 
appraisal (Zinzow and Jeffirs, 2018). We have previously shown in the EPSTB Sample 1 of 
this study that driving while impaired is highly recurrent, and that even in terms of other, 
additional traffic violations the repeat DWI drivers represent the most hazardous group of car 
drivers (Tokko et al., 2019). Driving while impaired is a high-risk behaviour that derives not 
just from the drinking problems but also temperament, personality, and development of basic 
behavioural tendencies (Stacy et al., 1991). The present study has found that recurrent DWI is 
more frequent in the HCRTR1 A/A homozygotes. Drunk driving was not more prevalent with 
this genotype in subjects with no record of major traffic violations, and if anything it was 
lower in drivers who had to a very significant extent exceeded speed limits. This suggests a 
rather specific relationship of HCRTR1 A/A homozygocity with drunk driving: It appears to 
aggravate problems with behavioural regulation in subjects who use alcohol irresponsibly. In 
the drunk drivers group the cumulative causing of traffic accidents was lower in HCRTR1 
G/G homozygotes than in the A-allele carriers. Among the speed limit exceeders a rather 
different trend of the A/A homozygotes to cause less traffic accidents was revealed, but 
indeed the speed limit exceeders and drunk drivers have very different personality profiles 
(Paaver et al., 2006). We next examined the association of the HCRTR1 genotype with traffic 
accidents in a different sample of younger passenger car drivers that was recruited directly in 
traffic schools and consisted of both males and females. It was observed again that the 
genotype was associated with the active traffic accidents. The HCRTR1 A/A homozygotes 
had the highest cumulative accident rate of accidents, while the G/G homozygotes had the 
lowest. Given that the findings in these younger and less experienced car drivers resembled 
those obtained only in drunk drivers if the sample had longer driving records, it could be 
hypothetized that the HCRTR1 genotype relates to accident proneness in conditions of low 
behavioural control. 
Previously, orexins have been implicated in coordinating defense response but mostly 
without focus on aggressiveness. However, one highly relevant study on epileptic patients 
monitored the release of orexin A in amygdala and found it to be increased while subjects 
reported higher levels of anger, but also more universally during social interactions; 
particularly high levels were observed during experiencing positive emotions (Blouin et al., 
2013). Orexin A overflow was not related to arousal unspecifically, as it did not occur if 
arousal was related to postoperative pain. These findings in humans are consistent with data 
showing higher orexin neuron firing during operant reinforcement (Borgland et al., 2009; 
McGregor et al., 2011; Sharf et al., 2010). It is however not clear what is the respective 
contribution of ORX1 and ORX2 receptors in these responses. The ORX2 receptors were 
recently shown to contribute to emotion-related adaptive strategies dependent on 
environmental conditions (Staton et al., 2018). 
To understand fully the neurobiological mechanisms behind the findings presented herewith, 
further information would be needed on the functional consequences of the HCRTR1 
rs2271933 G > A variation. The G1222A variation leads to amino acid substitution in the 
region of receptor that may be interacting with G proteins and other proteins (Thompson et 
al., 2014), but direct in vitro evidence of functionality is missing, while the valine in the 
respective position could promote the phosphorylation of the immediately adjacent serine and 
alter signal transduction upon activation of the receptor (Meerabux et al., 2005). The A-allele 
was found to be associated with higher prevalence of major depressive disorder (Rainero et 
al., 2011a), with a tendency for a larger difference from control with the A/A homozygotes 
than with A/G heterozygotes; however, the association of migraine with the HCRTR1 
genotype rather rested on heterozygotes. These studies were not sufficiently large to suggest 
clearly the mode of inheritance. A recent study that separated migraine patients to those with 
aura and those without replicated the overrepresentation of the HCRTR1 A-allele in migraine 
patients without aura (Kowalska et al., 2018). The HCRTR1 genotype was not associated with 
narcolepsy in a small sample (Peyron et al., 2000) or with panic disorder (Annerbrink et al., 
2011). Nevertheless, the presented findings should increase interest in elucidating the 
possible functional role of the HCRTR1 rs2271933 G > A polymorphism and other gene 
variations in the orexin signalling system to reveal the genetic mechanisms of the role of 
orexins in the coordinated defense response. 
As a limitation of the presented study, the reader should be aware of the uncorrected p-values 
used throughout the text and illustrations. Given that the fair level of correction is not simple 
to select for the intercorrelated measures, and that it would put limits to relevant analyses 
given the fixed sample sizes of longitudinal studies, it was preferred to present all analyses as 
exploratory and leave the decision of the appropriate significance level with the reader. The 
strength of the study is inclusion of multiple cohorts and convergence of findings with related 
yet independent constructs. 
Conclusively, we have found a consistent association of the HCRTR1 rs2271933 G > A 
variation with aggressiveness in two birth cohort samples. This gene polymorphism was also 
associated with high relapsing to drunk driving and with higher rate of causing traffic 
accidents among drivers with limited experience or hazardous driving behaviour. This 
evidence suggests on important role of orexins in the formation of aggressive responses and 
their control. 
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